GSK Investigational Site

San Isidro, Lima region Lima 27

0 studies enrolling now · 8 studies all time

What they study most

Adenocarcinoma, Asthma, Diabetes Mellitus, Type 2, Epilepsy, Tonic-Clonic, Pulmonary Disease, Chronic Obstructive

Studies at this site

• 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease — Completed
• A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma. — Completed
• Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma — Completed
• Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug — Completed
• Study In People With Type 2 Diabetes — Completed
• Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate — Completed
• A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus — Completed